Benzinga··Djs Law GroupGene Therapy Firm uniQure Faces Securities Class Action Over FDA Study Claims
uniQure faces class action lawsuit alleging misleading statements about pivotal study design and FDA approval prospects. Shareholders have until April 13, 2026 to join.
QUREsecurities fraudclass action lawsuit